Plant-based Wellness Done Better - CSE:PLNT OTCQB:BOSQF Frankfurt:YG3 - Better Plant Sciences Inc.
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Disclaimer Forward looking information Notice to Reader This presentation contains "forward looking information" within the meaning of applicable Canadian securities NeonMind is developing and commercializing products that contain legal medicinal mushrooms and legislation. Wherever possible, words such as "plans", "expects", or "does not expect", "budget", "scheduled", products with psychedelic compounds. While we are focused on developing products using "estimates", "forecasts", "anticipate" or "does not anticipate", "believe", "intend" and similar expressions or statements psychedelic compounds, we do not have any direct or indirect involvement with the illegal selling, that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, have been production or distribution of any substances in the jurisdictions in which it operates. We do not used to identify forward looking information. advocate for the legalization of any psychedelic substances and does not deal with psychedelic substances, and will only do so through agents within laboratory and clinical trial settings Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the conducted within approved regulatory frameworks. Our product candidates with psychedelic actual results, performance or achievements of The Yield Growth Corp. to be materially different from any future results, compounds will not be commercialized prior to applicable regulatory approval, which will only be granted if clinical evidence of safety and efficacy for the intended uses is successfully developed performance or achievements expressed or implied by the forward-looking information. Although The Yield Growth Corp. has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be Warning of Risk accurate, as actual results and future events could differ materially from those anticipated in such statements. An investment in our securities (the “Units”) should be considered highly speculative and investors may incur a partial or total loss of their investment. Investors should consult with their professional Forward looking statements are based on the reasonable assumptions, estimates, analysis and opinions of management advisors to assess an investment in the Units. made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. Management believes that the assumptions and Our activities are subject to risks normally encountered in a newly established business, including expectations reflected in such forward looking statements are reasonable. but not limited to: negative cash flow; competition; lack of adequate capital; liquidity concerns and future financing requirements to sustain operations; maintaining and promoting our brand and products; competition risk; key personnel risks; inability to protect intellectual property; intellectual property claims against us; risks associated with the supply of psilocybin from third parties; safety Market data disclaimer and efficacy of our products and product candidates; law and regulations relating to our business; no history of operations and revenues, and no history of earnings or dividends; global economic changes; uninsured risks; no public market for our common shares; risks associated with the impact This presentation includes market and industry data that has been obtained from third party sources including of COVID-19, and volatility in share prices. publications from various industries, and where appropriate, certain numbers, including dollar amounts, have been rounded out by us to avoid lengthy numbers. We believe that this industry data is accurate and that its estimates and assumptions are reasonable; however, there are no assurances as to the accuracy or completeness of this data. Third party sources generally state that the information contained therein has been obtained from sources believed to be reliable; however there are no assurances as to the accuracy or completeness of included information. Although the data is believed to be reliable, we have not independently verified any of the data from third party sources referred to in this presentation or ascertained the underlying economic assumptions relied upon by such sources. 2
Corporate Overview (BC) Urban Juve Provisions Inc. Wright & Well Essentials Inc. Thrive Activations Inc. YIELD UJ WRIGHT & WELL BOTANICALS BEVERAGES CBD Yield Botanicals Inc. UJ Beverages Inc. W&W Manufacturing Inc. NeonMind Biosciences Inc. 3
Multiple revenue streams via multiple subsidiary companies UJ Beverages Inc. Urban Juve Provisions Inc. ➔ Line of eight wellness beverage formulas to be ➔ Large portfolio of natural, plant-based skin care products infused with CBD and one capsule product intended ➔ Direct to consumer sales in North America via e-commerce site and Amazon to treat hangovers ➔ Retail partnerships in North America through Pharmasave, Vitasave & independent retailers Yield Botanicals Inc. ➔ Proprietary patent pending extraction technology combining Ayurveda Wright & Well Essentials Inc. therapeutic extraction methods with modern science and commercial ➔ Now launching 9 THC products into the Oregon market under the brand hemp root oil production Wright & Well NeonMind Biosciences Inc. W & W Manufacturing Inc. ➔ Developing and commercializing products that contain legal medicinal ➔ Legal US retail and e-commerce manufacturing and distribution channel for mushrooms and products with psychedelic compounds beauty, health and wellness brands with legal hemp and CBD products for ➔ Catalogue of mushroom formulas to be used in ready- to-consume distribution throughout the United States products such as coffee, tea, hot cocoa, elixirs and truffles ➔ Research on psychedelic medicine, with preclinical and clinical trials planned for 2020/2021 4
Target Market Canada & United States ➔ Global wellness market value of $4.2 trillion in 2015*. ➔ Global vegan cosmetics market expected to reach $20.8 billion by 2025** ➔ Global cannabis market value: Expected to surpass $31 billion by 2021*** ➔ Psychedelic medicine has potential to become a $100 billion industry upon legalization**** ➔ Limited direct competition in our area of focus: High-end, plant-based wellness products. * Global Wellness Institute “Statistics and Facts”. Summary accessible online at: *** Deloitte. “Insights into the recreational marijuana market: Exploring opportunities and challenges” accessible https://globalwellnessinstitute.org/press-room/statistics-and-facts/ online at: https://www2.deloitte.com/ca/en/pages/deloitte-analytics/articles/recreational-marijuana-market.htmla ** Grand View Research. “Vegan cosmetics market” accessible online at: **** Eight Capital accessible online at: https://www.grandviewresearch.com/press-release/global-vegan-cosmetics-market https://www.businessinsider.com/eight-capital-analyst-mindmed-psychedelics-industry-ammar-shah-2020 5
SUBSIDIARY HIGHLIGHT Urban Juve ● 200+ plant-based formulations and 12+ pending patents ● Available through Urban Juve ecommerce store, Amazon, Pharmasave, Vitasave & other retailers ● As seen in British Vogue, Elle Canada and UK Vogue ● Establishing influencer relationships to increase brand awareness on social media
SUBSIDIARY HIGHLIGHT Wright & Well Jack & Jane ● THC and CBD topical products ● CBD products based on proprietary method for hemp root extraction ● W&W available in Oregon, Jack & Jane launching in Canada soon ● Capitalizing on “Cannabis 2.0” product boom
SUBSIDIARY HIGHLIGHT NeonMind ● Creating medicinal mushroom health products, with initial launch of infused coffees ● Psychedelic medicine research, with 6 patents pending ● Chairman of the board is former Johnson & Johnson Chairman Jeff Smith ● Psilocybin pre-clinical trials anticipated to launch in 2020
Leadership Team Penny White Thomas Bond Jeff B. Smith Chairman of Better Plant Sciences Co-Founder, President & CEO, Director Advisor Advisory Board ● Serial entrepreneur and securities lawyer ● COO and CFO of M.A.C. Cosmetics from ● Chairman of the Board of Better Plant with over two decades of experience in 1993-1999, helping grow annual majority owned subsidiary NeonMind. online music, international film distribution, revenues from $12 million to over $300 Former Group Chairman and Global Chief mobile payments, consumer products, million, until the company was acquired by Transformation Officer and Group crowdsourcing, renewable energy, Estee Lauder (NYSE:EL) Chairman for Consumer North America for pharmaceuticals, e-commerce and ● 35 years experience partnering with Johnson & Johnson (NYSE:JNJ) cannabis entrepreneur businesses to build and ● Jeff’s division represented more than 42% ● Co-founder of Merus Labs Inc. (TSX:MSL, deliver the operational and financial of global revenue, and over US$6.5 billion NASDAQ:MSLI-Q), which was acquired by infrastructure to support annual in annual revenue with mid-single digit Norgine B.V. in 2017 for $342 million double-digit revenue growth holding growth rates. In 2011, Jeff was appointed ● Recognized in PROFIT Magazine's W100 C-level financial and operational positions President, U.S. Skincare for North America most successful entrepreneurs and with companies engaged in cosmetics, ● As President of Johnson & Johnson’s included in PROFIT 500 Fastest Growing apparel, and construction including M.A.C largest business unit, Jeff grew it from the companies in 2015 and 2016 Cosmetics, Cover FX Skin Care and Tridel 3rd largest skincare company to #1 in the U.S. over 3.5 years. 9
Leadership Team Continued Tamara Melck Amy Frankel Rick Huang Corporate Secretary, Chief Operating Officer Chief Financial Officer, Director General Counsel and VP People ● 16 years serving in multiple executive ● Former Co-General Counsel of Aritzia LP ● Former CFO of Hanwei Energy Services roles for fashion retailer Aritzia (TSX:ATZ), (TSX: ATZ) and Associate General Counsel corporation (TSX: HE) including Vice President, Corporate of Skechers USA Inc. (NYSE: SKX) ● Chair of the Audit Committee for 3 Tier Logic Operations and Executive Vice President, ● Over 15 years working in vertically (TSXV: TTM) and Chair of the Governance People & Culture. integrated consumer product retail industry Committee and member of the Audit ● Created several corporate backend ● Expertise negotiating license and ● Committee of Poydras Gaming Finance functions that allowed Aritzia to scale its distribution agreements and managing Corp. (TSXV: PYD) operations and achieve $743M in annual international intellectual property portfolios ● Negotiated for international joint ventures, revenue and a market capitalization of including drafting shareholders’ agreements, over $1 billion when she left in 2017. establishing international legal entities, and ● Juris Doctor and Master of Business assets transfers Administration from the University of British Columbia, a Master of Science in Journalism from Columbia University and completed the High Potentials Leadership Program at Harvard Business School. 10
Contact Investor Relations — invest@betterplantsciences.com P +1 833 515 2677 11
You can also read